Dataset DZNE-2023-00188

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Dataset: Mapping of TDP-43 ubiquitination and acetylation sites



2022
PRoteomics IDEntifications Database

PRoteomics IDEntifications Database ()

Abstract: TAR DNA binding protein of 43 kDa (TDP-43) forms aggregates in neurodegenerative diseases, particularly certain forms of frontotemporal dementia and amyotrophic lateral sclerosis. Pathological modifications of TDP-43 include proteolytic fragmentation, phosphorylation, and ubiquitinylation. In this study, we systematically mapped TDP-42 ubiquitination as well as acetylation sites.


Contributing Institute(s):
  1. Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases (AG Gloeckner)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2022
Click to display QR Code for this record

The record appears in these collections:
Document types > Other Resources > Datasets
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gloeckner
Public records
Publications Database


Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;
Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
The journal of biological chemistry 293(41), 16083-16099 () [10.1074/jbc.RA118.003440] pmc   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;
Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.
Nature Communications 13(1), 1223 () [10.1038/s41467-022-28822-7] OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS


 Record created 2023-01-27, last modified 2024-01-18


External link:
Download fulltext
Fulltext
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)